Initially, ABCG2 was considered a stem cell marker in bone marrow [92] and subsequently it became a potential stemness marker in HCC [94], as it was detected in HCC and various cancer types [95–97]. This evidence concerns the gene ABCG2 and hepatocellular carcinoma.